首页 › 胃癌 › 纽约州

纽约州的胃癌临床试验

纽约州有 38 项针对胃癌的研究正在招募参与者。

纽约州的城市

官方研究文本（英文）

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

招募中欢迎健康志愿者

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

招募中观察性研究欢迎健康志愿者

40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06172478

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site, Commack

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06219941

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Memorial Sloan Kettering Cancer Center, New York
Local Institution - 0274, Rochester

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07221149

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT07700979

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
以及另外 2 项

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07392892

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT07069712

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
以及另外 1 项

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07631000

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Commack

招募中2 期

18 至 130 岁 · 所有性别 · 更新于 2026年9月23日 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06128551

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Roswell Park Comprehensive Cancer Center, Buffalo

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月21日 · NCT05274048

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07217704

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
以及另外 1 项

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT07818018

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月10日 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, New York
Research Site, New York
Research Site, New York
以及另外 2 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Icahn School of Medicine at Mount Sinai, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT06253871

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Memorial Sloan Kettering Hospital, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月2日 · NCT07070232

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年8月27日 · NCT07227168

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Northwell Health Cancer Institute at Huntington, Greenlawn

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年8月26日 · NCT04329494

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年8月11日 · NCT06242470

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Memorial Sloan Kettering Cancer Center - MAIN, New York
Montefiore Medical Center, The Bronx

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年8月10日 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cayuga Medical Center, Ithaca
Mt. Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
以及另外 1 项

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年7月29日 · NCT03526835

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

START New York, Lake Success
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年7月15日 · NCT06657144

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Memorial Sloan Kettering Cancer Center, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年7月10日 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
以及另外 7 项

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年7月6日 · NCT04389632